Nebulized Albuterol for Congestive Heart Failure Exacerbation

Withdrawn before enrolling · Phase 2/Phase 3 · Has a placebo group

Conditions studied: Congestive Heart Failure

In brief

This is a randomized trial of the use of Albuterol in the setting of acute decompensated Congestive Heart Failure with radiographic evidence of Cardiogenic Pulmonary Edema.

Key facts

Study ID

NCT01375361

Run by

University of California, San Francisco

People needed

0

Starts

2009-04-01

Last updated by the study team

2013-10-10

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• age 18-65 with shortness of breath and history of CHF
• pulmonary edema on chest xr

You may not qualify if…

• pregnancy
• clinical or ekg changes to suggest acute coronary syndrome
• history of copd or asthma
• history of albuterol on medication list

Where it is running

• University of California — San Francisco, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.